Calendar second-quarter earnings for the hospital supplies group are scheduled to kick-off on July 19th, Morgan Keegan reports.
“Going into earnings, our favorite long ideas are Outperform rated Baxter BAX ($70 PT) and Covidien COV ($63 PT), and Market Perform rated Hill-Rom Holdings, Inc. HRC ($48 PT),” Morgan Keegan writes.
“In our opinion, Baxter has potential for EPS upside due to improving margins and solid top-line growth. For Covidien, we expect stable surgical procedure volumes, share repurchase, and positive FX to provide above consensus EPS. For Hill-Rom, we believe that operating margin guidance was conservative for the 2H, which leaves room for upside to EPS, an increase in 2011 guidance, and a trading opportunity in the shares.”
Baxter closed Monday at $59.88; Hill-Rom closed at $45.08; Covidien closed at $52.29.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in